Brean Murray Carret Raises Price Target on Achillion Pharmaceuticals (ACHN) Due to ACH-1625 Clinical Profile
Go back to Brean Murray Carret Raises Price Target on Achillion Pharmaceuticals (ACHN) Due to ACH-1625 Clinical Profile| Achillion Pharmaceuticals, Inc. (AMEX: ACHN) | Delayed: 0.79 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.79 | 52 Week High | $10.95 | |||
| Open | $15.10 | 52 Week Low | $3.78 | |||
| Day High | $0.79 | P/E | N/A | |||
| Day Low | $0.79 | EPS | $-0.63 | |||
| Volume | 504,330 | |||||
| Pharmasset, Inc. (AMEX: VRUS) | Delayed: 0.00 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.00 | 52 Week High | $137.81 | |||
| Open | $67.86 | 52 Week Low | $46.49 | |||
| Day High | $0.00 | P/E | 0.00 | |||
| Day Low | $0.00 | EPS | $-1.25 | |||
| Volume | 34,954 | |||||
